Soluble RAGE (sRAGE)
Soluble RAGE as a severity marker in community acquired pneumonia associated sepsis
8
Effect of glycemic control on soluble RAGE and oxidative stress in type 2 diabetic patients
8
RAGE and Soluble RAGE: Potential Therapeutic Targets for Cardiovascular Diseases
11
Soluble RAGE and atherosclerosis in youth with type 1 diabetes: a 5-year follow-up study
8
Soluble RAGE but not endogenous secretory RAGE is associated with albuminuria in patients with type 2 diabetes
5
Soluble receptor for advanced glycation end product (sRAGE)/pentosidine ratio: a potential risk factor determinant for Type 2 diabetic retinopathy
12
S100A8/A9 and sRAGE kinetic after polytrauma; an explorative observational study
6
Soluble receptor for advanced glycation end products in critically ill patients and its associations with other clinical markers and 28-day mortality
6
Decreased levels of soluble receptor for advanced glycation end products in patients with rheumatoid arthritis indicating deficient inflammatory control
8
Association of Serum Soluble Receptor for Advanced Glycation End Products (sRAGE), S100A12, and VCAM 1 Levels with Further Post Coronary Angiogram Endothelial Injury in Elderly and Younger Patients
11
Association of serum soluble receptor for advanced glycation end products (sRAGE), S100A12, and VCAM-1 levels with further post-coronary angiogram endothelial injury in patients with Coronary Artery Disease (CAD) and stenosed coronary vessels
17
Evolution and bad prognostic value of advanced glycation end products after acute heart failure: relation with body composition
11
Multimodal imaging of the receptor for advanced glycation end-products with molecularly targeted nanoparticles
13
The potential role of advanced glycation end products (AGEs) and soluble receptors for AGEs (sRAGE) in the pathogenesis of adult onset still’s disease
9
Original Article Impact of hyperglycemia and acute pancreatitis on the receptor for advanced glycation endproducts
9
sRAGE in diabetic and non diabetic critically ill patients: effects of intensive insulin therapy
10
The presence of high mobility group box-1 and soluble receptor for advanced glycation end-products in juvenile idiopathic arthritis and juvenile systemic lupus erythematosus
9
A REVIEW ON DIABETES INDUCED MEMORY IMPAIRMENT
6
Narratives of Rage and Rehabilitation: Hyper Marginality and the Strategies of Resistance in Jamaica Kincaid’s My Brother and Mr. Potter
22
Reverse regulation of soluble receptor for advanced glycation end products and proinflammatory factor resistin and S100A12 in Kawasaki disease
7